'Special K': A Potential Treatment for OCD?
Stanford Medicine's Scope Podcast interviews Dr. Rodriguez about her research using ketamine to relieve symptoms of OCD.
Early Test Shows: Experimental Drug May Have Potential to Relieve OCD Symptoms Quickly and with Few Side Effect
A new article in Brain & Behavior Research Foundation's eNews came out today featuring Dr. Rodriguez's study in The American Journal of Psychiatry.
The study was an investigation of the drug rapastinel as a replacement for ketamine in the treatment of OCD symptoms.
Veterans Affairs Research Week Fair - May 17th, 2017
Maria and Jordan manned the Rodriguez Lab booth at this year's VA Research Week Fair.
The Rodriguez Lab is proud to partner with the Palo Alto VA for research projects which better the lives of veterans and their families.
11th Annual Cardinal Walk - May 4th, 2017
The Rodriguez Lab participated in our second annual Cardinal Walk.
This year's theme was "Moonwalk to Wellness." May the 4th be with you all!
Anxiety & Depression Association of America Conference - April 6-9, 2017
The Rodriguez Lab presented 5 posters at this year's ADAA conference in San Francisco.